Search
SOLACI Congress
HomeFile

File

View Category
Acute coronary syndromes

EuroPCR 2020 | FABOLUS FASTER: In the Quest for the Fastest, Most Potent Platelet Inhibition

This small study tested the pharmacodynamic effects of several antiplatelet agents. It concluded that tirofiban (Aggrastat) provides...
solaci -
Learn More
Coronary Disease

EuroPCR 2020 | Deferral Based on iFR vs. FFR: Are They Equivalent or Is There a New “Gold Standard”?

Age may impact results when making an angioplasty choice based on fractional flow reserve (FFR) vs. instantaneous...
solaci -
Learn More
Mitral valve

EuroPCR 2020 | CLASP: New Device for Mitral Repair with at One Year Follow Up

The CLASP looked into patients treated with the new device for transcatheter mitral repair called PASCAL and...
solaci -
Learn More
Chronic Ischemic cardiopathy

EuroPCR 2020 | Revascularization vs. Initial Medical Treatment in Chronic Patients

There is no survival advantage with invasive coronary revascularization over initial medical treatment in patients with chronic...
solaci -
Learn More
Structural Heart Disease

EuroPCR 2020 | EVOQUE: New Transcatheter Mitral Valve Replacement System, Promises at Short Term and Future Hope

Transeptal transcatheter mitral valve replacement offers a less invasive alternative vs. surgery and with fewer anatomical limitations...
solaci -
Learn More
Acute coronary syndromes

EuroPCR 2020 | Sudden Death Increase Two to Three Times While MI Rate Falls

The number of sudden deaths reported around the world is on the rise in Covid-19 times. These...
solaci -
Learn More
Peripheral Vascular Disease

EuroPCR 2020 | Is Renal Denervation Coming Back to Life?

Additional analyses from the Global SYMPLICITY Registry and the RADIANCE-HTN SOLO trial, presented virtually at EuroPCR 2020, can...
solaci -
Learn More
Aorta

Anesthetic Modes and Their Impact on Elective Endoprostheses

This work supports previous observations on the mortality benefit of regional (and even local) anesthesia in patients...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Dr. Omar Tupayachi - 0
Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Dr. Omar Tupayachi - 0
Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

Is upper-limb aerobic training an effective alternative to lower-limb exercise in peripheral artery disease?

Dr. Juan Manuel Pérez - 0
Peripheral artery disease is associated with impaired functional capacity, reduced walking distance, and poorer quality of life, and structured exercise is a class I...

Institutional News

Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition

solaci - 0
Registration is now open for the SOLACI–CACI Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition. The program is intended for physicians with...

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy